November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP
Apr 20, 2024, 07:03

Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP

Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, shared a post on X:

Dasatinib and Venetoclax is safe and effective in newly diagnosed Chronic Myeloid Leukaemia in CP, but no better than single-agent Dasatinib, longer follow-up needed to evaluate impact on TFR.”

Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP

Additional information.
Source: Hagop Kantarjian/X